143 related articles for article (PubMed ID: 32959249)
1. O-Antigen Extraction, Purification, and Chemical Conjugation to a Carrier Protein.
Micoli F; Giannelli C; Di Benedetto R
Methods Mol Biol; 2021; 2183():267-304. PubMed ID: 32959249
[TBL] [Abstract][Full Text] [Related]
2. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F
Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella paratyphi A and used for vaccine preparation.
Ravenscroft N; Cescutti P; Gavini M; Stefanetti G; MacLennan CA; Martin LB; Micoli F
Carbohydr Res; 2015 Mar; 404():108-16. PubMed ID: 25665787
[TBL] [Abstract][Full Text] [Related]
4. Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines.
De Benedetto G; Salvini L; Gotta S; Cescutti P; Micoli F
Bioconjug Chem; 2018 May; 29(5):1736-1747. PubMed ID: 29697244
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic studies of the structure and stability of glycoconjugate vaccines.
Jones C; Lemercinier X; Crane DT; Gee CK; Austin S
Dev Biol (Basel); 2000; 103():121-36. PubMed ID: 11214231
[No Abstract] [Full Text] [Related]
6. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
[TBL] [Abstract][Full Text] [Related]
7. Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar Recycling.
Stefanetti G; Saul A; MacLennan CA; Micoli F
Bioconjug Chem; 2015 Dec; 26(12):2507-13. PubMed ID: 26549104
[TBL] [Abstract][Full Text] [Related]
8. Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM
Stefanetti G; Allan M; Usera A; Micoli F
Glycoconj J; 2020 Oct; 37(5):611-622. PubMed ID: 32535667
[TBL] [Abstract][Full Text] [Related]
9. O:2-CRM(197) conjugates against Salmonella Paratyphi A.
Micoli F; Rondini S; Gavini M; Lanzilao L; Medaglini D; Saul A; Martin LB
PLoS One; 2012; 7(11):e47039. PubMed ID: 23144798
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P
Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455
[TBL] [Abstract][Full Text] [Related]
11. Glycoconjugate vaccines: some observations on carrier and production methods.
MacCalman TE; Phillips-Jones MK; Harding SE
Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
[TBL] [Abstract][Full Text] [Related]
12. Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate vaccine.
Farkas P; Korcová J; Kronek J; Bystrický S
Eur J Med Chem; 2010 Feb; 45(2):795-9. PubMed ID: 19939517
[TBL] [Abstract][Full Text] [Related]
13. Oligosaccharide Antigen Conjugation to Carrier Proteins to Formulate Glycoconjugate Vaccines.
Smith BR; Guo Z
Methods Mol Biol; 2021; 2183():305-312. PubMed ID: 32959250
[TBL] [Abstract][Full Text] [Related]
14. A coordinated synthesis and conjugation strategy for the preparation of homogeneous glycoconjugate vaccine candidates.
Grayson EJ; Bernardes GJ; Chalker JM; Boutureira O; Koeppe JR; Davis BG
Angew Chem Int Ed Engl; 2011 Apr; 50(18):4127-32. PubMed ID: 21455919
[No Abstract] [Full Text] [Related]
15. Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification.
Berti F; Adamo R
Chem Soc Rev; 2018 Dec; 47(24):9015-9025. PubMed ID: 30277489
[TBL] [Abstract][Full Text] [Related]
16. O-phthalaldehyde based quantification of polysaccharide modification in conjugate vaccines.
Rajendar B; Reddy MVNJ; Suresh CNV; Rao GS; Matur RV
J Pharm Biomed Anal; 2024 Apr; 241():115995. PubMed ID: 38309096
[TBL] [Abstract][Full Text] [Related]
17. Synthetic carbohydrate-based vaccines: challenges and opportunities.
Mettu R; Chen CY; Wu CY
J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
[TBL] [Abstract][Full Text] [Related]
18. Investigation of novel cyclic structure in glycoconjugate using a simple model system.
Huang W; Wang HL; Wang M; Davis K; Xie J; Brown PW; Kolodziej SA; Zou Q; Carroll JA; Rouse J; Friese O; Jones M
Carbohydr Res; 2020 Sep; 495():108103. PubMed ID: 32807353
[TBL] [Abstract][Full Text] [Related]
19. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine.
Phalipon A; Costachel C; Grandjean C; Thuizat A; Guerreiro C; Tanguy M; Nato F; Vulliez-Le Normand B; Bélot F; Wright K; Marcel-Peyre V; Sansonetti PJ; Mulard LA
J Immunol; 2006 Feb; 176(3):1686-94. PubMed ID: 16424198
[TBL] [Abstract][Full Text] [Related]
20. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
Berti F; Micoli F
Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
